Close Menu

Whole-genome sequencing is still very expensive, but it is being used to make a difference in the lives of patients with rare diseases, says Richard Knox at the NPR Shots blog. Clinicians were able to treat Alexis and Noah Beery — 14-year-old twins afflicted with a rare disease called dopa-responsive dystonia — with a simple and effective therapy for their disease after they underwent whole-genome sequencing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.